Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHKA | P35790 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | RARB | P10826 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19607242 | 0.84 | PKM (0.49) | ALDH1A1RAB9ALMNAMAPTSMN1; SMN2 | |
| SCHEMBL19601129 | 0.83 | ACHE (0.39) | RAB9ALMNAHTTACHE | |
| SCHEMBL19601103 | 0.79 | KDM4A (0.43) | CHKAALDH1A1KDM4ERAB9ABCHE | |
| SCHEMBL19601104 | 0.78 | ALDH1A1 (0.58) | CHKAALDH1A1KDM4ERAB9ALMNA | |
| SCHEMBL19601091 | 0.73 | ALDH1A1 (0.55) | CHKAALDH1A1KDM4ERAB9ALMNA | |
| SCHEMBL19888149 | 0.70 | PKM (0.48) | ALDH1A1RAB9AMAPTSMN1; SMN2ACHE | |
| SCHEMBL19607399 | 0.70 | ACHE (0.48) | ALDH1A1MAPTSMN1; SMN2ACHE | |
| SCHEMBL8122311 | 0.70 | ALDH1A1 (0.61) | ALDH1A1KDM4ERAB9ALMNAMAPT | |
| SCHEMBL18775302 | 0.70 | KMT2A (0.53) | CHKAALDH1A1KDM4ERAB9ALMNA | |
| SCHEMBL13675283 | 0.69 | ALDH1A1 (0.55) | ALDH1A1KDM4ERAB9ARARBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170329195-A1 | ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME | CANON KABUSHIKI KAISHA (JP) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170329195-A1 | ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME | KCNJ2, KCNH3, KCNN2 | CHKA 1369/4885ALDH1A1 2072/4885KDM4E 2805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.